Evidence map›Paper›PMID 38898588›Full record

ArticleESC heart failure2024

Successful management of coronavirus disease 2019-associated myocardial injury and capillary leak syndrome: A case report.

Terufumi Iwanaga, Tasuku Hada, Keiko Ohta-Ogo, Shotaro Komeyama, Hiroki Mochizuki, Kohei Tonai, Naoki Tadokoro, Yoshihiko Ikeda, Satoshi Kainuma, Takuya Watanabe and 3 more

Abstract readCase ReportsLetter
In one paragraph

Article in ESC heart failure, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Terufumi IwanagaDepartment of Transplant Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.
Tasuku HadaDepartment of Transplant Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.ORCID 0000-0003-1995-2733
Keiko Ohta-OgoDepartment of Pathology, National Cerebral and Cardiovascular Center, Suita, Japan.
Shotaro KomeyamaDepartment of Transplant Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.
Hiroki MochizukiDepartment of Transplant Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.
Kohei TonaiDepartment of Cardiovascular Surgery, National Cerebral and Cardiovascular Center, Suita, Japan.
Naoki TadokoroDepartment of Cardiovascular Surgery, National Cerebral and Cardiovascular Center, Suita, Japan.
Yoshihiko IkedaDepartment of Pathology, National Cerebral and Cardiovascular Center, Suita, Japan.
Satoshi KainumaDepartment of Cardiovascular Surgery, National Cerebral and Cardiovascular Center, Suita, Japan.
Takuya WatanabeDepartment of Transplant Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.
Kinta HatakeyamaDepartment of Pathology, National Cerebral and Cardiovascular Center, Suita, Japan.
Satsuki FukushimaDepartment of Cardiovascular Surgery, National Cerebral and Cardiovascular Center, Suita, Japan.
Yasumasa TsukamotoDepartment of Transplant Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Capillary Leak SyndromeCOVID-19HumansSARS-CoV-2Capillary leak syndromeCardiogenic shockCoronavirus disease 2019Immunosuppressive therapyMechanical circulation support

Identifiers

PMID38898588
PMCPMC11424283

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.